Bogdan Agavriloaei
@thekidneywhisperer.bsky.social
I'm a young nephrologist from Iași, România, currently doing my phd on ADPKD and started an internship at #nephjc https://t.crdtg2.com/331727/5165?aff_sub5=SF_006OG000004lmDN
My first blog for @kireports.bsky.social. Thank you to my mentors @nephroseeker.medsky.social @brianrifkin.bsky.social @sophia-kidney.bsky.social
Brian Rifkin@brianrifkin.bsky.social · 6mo ago📖Check out the latest @kireports.bsky.social community blog on slowing ADPKD from @thekidneywhisperer.bsky.social #NephSky #MedSky www.kireportscommunity.org/post/stoppin...
Next nephJC is about SGLT2 in Kidney transplant patients! Come and join us!
Nephrology Journal Club@nephjc.bsky.social · 8mo agoHey #NephSky 2/10/26 at 9 pm EST we'll discuss #Flozinating into the Future & Beyond... SGLT2i in kidney transplant recipients. What's the latest evidence of risk/benefit? Do #Flozins act mechanistically the same in de-innervated kidneys? Come chat. www.nephjc.com/news/inifinti-flozins-transplant
here is the V for the INFINITI study of SGLT2 in trx! Check this out!
Nephrology Journal Club@nephjc.bsky.social · 8mo agoHere is the VA for the INFINITI study of SGLT2i in transplant patients by @glomerican.bsky.social #NephSky #Flozins #Flozination www.nephjc.com/news/2026/2/8/infiniti-the-visual-abstract
high normal range of K reduce ICD shocks? #nephJC
Nephrology Journal Club@nephjc.bsky.social · 8mo ago🍌🥑Can pushing K⁺ to the high-normal range reduce ICD shocks and hospitalizations? 🎨 #Visualabstract by @jeyakumarmeyyappan.bsky.social ⏰ #NephJC chat on Jan 27, 9 pm EST www.nephjc.com/news/2026/1/...
potassium goals and cardiac arrhythmias ? check out next nephJC
Nephrology Journal Club@nephjc.bsky.social · 8mo agoOh, the weather outside is frightful 🥶🥶 But #NephJC is so delightful, and since you've no place to go #NephSky... Come discuss POTCAST: potassium goals and cardiac arrhythmias 1/27/26 at 9pm EST on #Bluesky Summary by @shelliefravel.bsky.social @salinesolut.bsky.social www.nephjc.com/news/potcast
Check out the summary!
Nephrology Journal Club@nephjc.bsky.social · 8mo ago1/10 Last #NephJC we discussed Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN #TenPostNephJC Given the central role of complement dysregulation in C3 glomerulonephritis, we assessed whether complement-targeted therapies confer therapeutic benefit. www.nejm.org/doi/full/10....
Check out the VALIANT study!
Nephrology Journal Club@nephjc.bsky.social · 9mo agoWilst thou join us here, where the Sky is Blue? #NephJC On 1/13/26 at 9pm EST 'tis true We shall converse of the great knight's quest, a VALIANT effort from Sir Pegcetacoplan vs complement! ⚔️ www.nephjc.com/news/valiant-c3g
✨It's that time of the year again, to nominate the most deserving people in our community for #NephJCKidneys award 👇Here's a reminder of previous winners #Nephsky 📌You can nominate worthy individuals/ initiatives by using the hashtag or by using the form www.nephjc.com/news/2026/1/...
Check our list from 2025!
Nephrology Journal Club@nephjc.bsky.social · 9mo agoIt's 2026!🎉 We will be counting down the Top Ten Nephrology Stories of 2025 on 1/6/26 at 9 pm EST. Join us on TWITTER (it will always be Twitter to us). Come on by #NephJC faithful for a lively discussion! You picked & we're count'em down. www.nephjc.com/news/2025/1/3/top-stories-in-nephrology-2025
Less dialysis in AKI ? #nephJC Check-out our next chat and check our blog!
Nephrology Journal Club@nephjc.bsky.social · 9mo agoJoin us for the last #NephJC of 2025, 12/16/25 at 9pm EST!🥳 How soon should we withhold dialysis in AKI? We're discussing the LIBERATE-D trial #NephSky This one might just change your mind 🧠🧠 Blog by @msocomd.bsky.social and @sejalplakhani.bsky.social www.nephjc.com/news/liberated-aki
IgA nephropathy guideline! #nephJC
Nephrology Journal Club@nephjc.bsky.social · 10mo ago2/10 What'd I miss? Amazing how quickly IgAN guidelines have evolved – 2021 to 2025 has been a whirlwind! And what was once just a ‘future research direction’ is now front-and-center with real data. Feels like we’re witnessing the “ORIGIN” story of a new era in IgAN therapeutics!
Bicarbonate in dialysis? #nephJC
Nephrology Journal Club@nephjc.bsky.social · 10mo ago#NephJCshort on BICAR-ICU2 #Medsky #Nephsky ✍️ By @nephroseeker.medsky.social 🎭 Bicarbonate makes the picture look cleaner: better pH, more time. But beneath the smoother numbers, the patient hasn't changed. It's the same story, just told in softer colors www.nephjc.com/news/2025/10...
Got #KidneyWk FOMO like @nephroseeker.medsky.social ? We got you covered with daily coverage of the simultaneous publications! www.nephjc.com/news/kidneyw...
Kidney Week in Houston: Day 1 — NephJC
in this edition: Atacicept in IgAN; Albuminuria as a surrogate outcome, Renal Remission and additional CONFIDENCE analysis
nephjc.com
The 2025 @kdigo.org IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over #Nephsky #Medsky ✍️Summary by @thekidneywhisperer.bsky.social and @glomerican.bsky.social www.nephjc.com/news/igan-kd...
2025 IgAN KDIGO guidelines: fresh out of press, already aging gracefully — NephJC
This week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy
nephjc.com
Nephrology Journal Club@nephjc.bsky.social · 11mo agoLast #NephJC short on individual data meta-analysis showing that although we love flozins for their extensive benefits we actually don’t completely understand how they work #Nephsky ✍️Meta by @willkidney.bsky.social & co 📝 Write up by @nephroseeker.medsky.social www.nephjc.com/news/2025/10...
Check at the VA for our discussion of protein diet strategies by @msocomd.bsky.social. Is restricting protein in CKD and pushing protein in ESRD #TWDFNR? www.nephjc.com/news/2025/10...
Protein supplementation in CKD: The Visual Abstract — NephJC
We like protein, or do we? Low protein, high protein, supplements…what’s a nephrologist to do?
nephjc.com
Up next! Everybody is welcome!
Nephrology Journal Club@nephjc.bsky.social · 12mo agoUp next! CKD & Protein: Is Your Diet a Solution or a Silent Stressor? 🥩🔍 On October 14, we're discussing protein diets and outcomes in CKD/ESRD which still remains an enigma. ☀️📚 #NephJC pubmed.ncbi.nlm.nih.gov/40876553/ #Skytorial by @nephromommy-akshu.bsky.social Akshaya's signing off 👋
New era for kidney transplant?
Cristina Popa@nephroseeker.medsky.social · 12mo agoFrom MDR-101 to the Vienna trials, the message is clear: pairing donor marrow with precise immune regulation can shift kidney transplant care from lifelong suppression toward true, engineered tolerance #nephjc #nephsky www.nephjc.com/news/2025/30...
New era for kidney transplant ? Check out our NephJC blog!
Nephrology Journal Club@nephjc.bsky.social · 12mo agoChimerism might just be the 🔑 to immune tolerance and ending the need for immunosuppression 🚫💊after transplantation 🫘. Join the discussion 9/30/25 at 9 pm EST on Bluesky #NephSky #MedSky #NephJC www.nephjc.com/news/chimera-tolerance-njqe334
It's that time of year again 🍂🍂🍂 The #NephJC Fall pledge drive. Plese give if you are able to support our decades long mission of #FOAMed for all. #NephSky #MedSky www.nephjc.com/news/2025/9/22/nephjc-fall-pledge-drive
NephJC 2025 Fall Pledge Drive — NephJC
Help keep NephJC a vital, original, and unbiased source of medical education.
nephjc.com
Change is in the Autumn air 🌬️🍂 Join use only on #Bluesky on 9/16/25 at 9pm EST. We're discussing the 2025 ACC/AHA Hypertension Guideline Update. 🫀🫘🧠 #NephSky #MedSky www.nephjc.com/news/accaha2025-klno3
PREVENT, Detect, Treat: What’s New in the 2025 Hypertension Toolkit — NephJC
This week, we will discuss the AHA/ACC 2025 hypertension guideline update. Wow, have eight years flown by?
nephjc.com
Join us on nephJC chat!
Nephrology Journal Club@nephjc.bsky.social · last yr.Join us 9/2/25 at 9pm EST. We will discuss the use of spironolactone in patients on dialysis to prevent t cardiovascular outcomes and heart failure hospitalizations. Invite your friends. #NephJC #NephSky www.nephjc.com/news/achieve
First assignment at nephJC!
Nephrology Journal Club@nephjc.bsky.social · last yr.Last #NephJC we discussed the significance and causes of eGFRdiff, the difference between eGFR creatinine and cystatin C (eGFRdiff= eGFRcys-eGFRcr) #TenPostNephJC #NephSky Read the article 👇 pubmed.ncbi.nlm.nih.gov/40373998/
On 7/22/25 at 9pm EST only on Bluesky! #NephSky #MedSky join us for a lively discussion. We're debating eGFRdiff (the gap that is sometimes present between the eGFR of cystatin C and creatinine). What does it mean, what causes it and what you should do about it. #NephJC www.nephjc.com/news/egfrdiff
Mind The Gap: When eGFR Creatinine and Cystatin C Disagree — NephJC
This week, we will discuss the clinical significance of eGFRdiff, the difference in eGFRcys (cystatin C) and eGFRcr (creatinine).
nephjc.com
